![[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]](https://cddf.org/wp-content/uploads/2024/07/Capture-4-400x250.jpg)
[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]
The Cancer Drug Development Forum (CDDF) held a live webinar on Bayesian Approaches in Drug Development on 11 July 2024. In this webinar, Rob Hemmings (Consilium) gave an insightful talk followed by a Q&A discussion moderated by Axel Glasmacher (CDDF) and Eva...
🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)
The Cancer Drug Development Forum (CDDF) is delighted to announce that a white paper, “Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action” has been published in European Journal of Cancer (Vol 209, September 2024). This paper has been developed...
🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024
Check out the hybrid joint HMA/EMA multi-stakeholder workshop on Artificial Intelligence (AI) that will be held on 5 November 2024. The objectives of the workshop is to provide an update on the state-of-the-art of AI developments with keynote speakers: Update...
![[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]](https://cddf.org/wp-content/uploads/2024/07/Capture-2-400x250.jpg)
[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]
The Cancer Drug Development Forum (CDDF) held a live webinar on Cancer Medicines Forum on 25 June 2024. In this webinar, Denis Lacombe (EORTC, BE) provided an interesting talk followed by a Q&A discussion moderated by Rosa Giuliani (CDDF, UK) and Daniel Goldstein...
ACT EU: Materials from MSP AG Meeting – 4 July 2024
Check out presentation slides from the MSP AG Meeting that took place on 4 July 2024 and stay up to date on topics of interest for clinical trials in the EU. Multi-stakeholder platform - European Union (europa.eu)
ACT EU: Faster Access to Clinical Trial Information in Europe
The launch of a new version of the Clinical Trials Information System (CTIS) is giving earlier and more efficient access to clinical trial information in Europe. Revised transparency rules eliminate deferral mechanisms providing public access to approximately 4000...
ACT EU: Two New Advice Pilots to Improve Clinical Trials in Europe
On 10 June 2024, the Accelerating Clinical Trials in the EU (ACT EU) initiative launched two advice pilots aimed at improving the quality of applications for clinical trials, the foundation for the development of safe and effective medicines in Europe. For more...
Nomination of New Vice Chairperson: Professor Stefan Symeonides
The Cancer Drug Development Forum (CDDF) is delighted to announce that Professor Stefan Symeonides has been nominated as new Deputy Chairperson for a three-year term, succeeding Professor Eva Skovlund. This nomination took effect on 23 May 2024 following the CDDF...
Warm Welcome for PharmaMar to the CDDF Multi-Stakeholder Community
🎉 📣 The Cancer Drug Development Forum (CDDF) is excited to introduce our new Industry member, PharmaMar, who will make collaborative efforts with the CDDF in order to improve the healthcare outcomes of cancer patients. PharmaMar is a unique company as a pioneer of...